Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia
- PMID: 35616656
- DOI: 10.1007/s00134-022-06754-6
Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia
Comment in
-
Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Reply of the Editor in Chief.Intensive Care Med. 2022 Jul;48(7):965-966. doi: 10.1007/s00134-022-06758-2. Epub 2022 Jun 6. Intensive Care Med. 2022. PMID: 35668221 No abstract available.
Comment on
-
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.Intensive Care Med. 2022 Jul;48(7):841-849. doi: 10.1007/s00134-022-06690-5. Epub 2022 May 13. Intensive Care Med. 2022. PMID: 35552788 Clinical Trial.
References
-
- Bougle A et al (2022) Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med. https://doi.org/10.1007/s00134-022-06690-5 - DOI - PubMed
-
- Chastre J et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(19):2588–2598 - DOI
-
- Schumi J, Wittes JT (2011) Through the looking glass: understanding non-inferiority. Trials 12:106 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
